Literature DB >> 10727977

Aberrant P-cadherin expression is a feature of clonal expansion in the gastrointestinal tract associated with repair and neoplasia.

D S Sanders1, I Perry, R Hardy, J Jankowski.   

Abstract

The recognition of key roles for cadherins in the determination of epithelial cell phenotype, migration, differentiation, and tumour dissemination have stimulated much interest in this family of adhesion molecules. In the gastrointestinal tract, alteration of the expression of classical cadherins with aberrant P-cadherin up-regulation, associated with co-expression or loss of E-cadherin expression, is seen in neoplastic transformation of oral and oesophageal squamous mucosa and in lesions representing early neoplastic transformation of glandular mucosa, such as aberrant crypt foci and metaplastic and adenomatous polyps. This same phenotype is seen in enterocytes adjacent to foci of ulceration in the intestine in colitis, including inflammatory bowel disease, and in colitis-associated dysplasia. In coeliac disease, reversible E-cadherin down-regulation correlates with the degree of villous atrophy, but in contrast with colitis, aberrant P-cadherin expression is not a feature. Aberrant epithelial P-cadherin expression is thus associated with a proliferative phenotype related to ulceration and neoplastic transformation in the gastrointestinal tract, which may confer a survival advantage on these cells, but the relative functional roles of P-cadherin and E-cadherin and the molecular mechanisms underlyingP-cadherin/catenin interactions have yet to be elucidated. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727977     DOI: 10.1002/(SICI)1096-9896(200004)190:5<526::AID-PATH564>3.0.CO;2-9

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

Review 1.  Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.

Authors:  D S A Sanders
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

2.  Endometriotic cells exhibit metaplastic change and oxidative DNA damage as well as decreased function, compared to normal endometrium.

Authors:  M Slater; G Quagliotto; M Cooper; C R Murphy
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

3.  Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomas.

Authors:  Daisuke Matsubara; Shumpei Ishikawa; Oguni Sachiko; Hiroyuki Aburatani; Masashi Fukayama; Toshiro Niki
Journal:  Am J Pathol       Date:  2010-10-07       Impact factor: 4.307

4.  E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome.

Authors:  Adam Elzagheid; Annika Algars; Riyad Bendardaf; Hanan Lamlum; Raija Ristamaki; Yrjo Collan; Kari Syrjanen; Seppo Pyrhonen
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

5.  P-Cadherin Regulates Intestinal Epithelial Cell Migration and Mucosal Repair, but Is Dispensable for Colitis Associated Colon Cancer.

Authors:  Nayden G Naydenov; Susana Lechuga; Ajay Zalavadia; Pranab K Mukherjee; Ilyssa O Gordon; David Skvasik; Petra Vidovic; Emina Huang; Florian Rieder; Andrei I Ivanov
Journal:  Cells       Date:  2022-04-27       Impact factor: 7.666

6.  P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.

Authors:  Lorenzo Lo Muzio; Giuseppina Campisi; Antonio Farina; Corrado Rubini; Giuseppe Pannone; Rosario Serpico; Gregorio Laino; Alfredo De Lillo; Francesco Carinci
Journal:  BMC Cancer       Date:  2005-06-21       Impact factor: 4.430

Review 7.  P-cadherin expression in breast cancer: a review.

Authors:  Joana Paredes; Ana Luísa Correia; Ana Sofia Ribeiro; André Albergaria; Fernanda Milanezi; Fernando C Schmitt
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

8.  Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin.

Authors:  Azza Ben Hamida; Intidhar S Labidi; Karima Mrad; Emmanuelle Charafe-Jauffret; Saïda Ben Arab; Benjamin Esterni; Luc Xerri; Patrice Viens; François Bertucci; Daniel Birnbaum; Jocelyne Jacquemier
Journal:  BMC Cancer       Date:  2008-01-29       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.